Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats

Brain Research

Volumn 797, Issue 1, 1998, Pages 94-102

  Enrico, Paolo ^a   Mura, Maria A ^a   Esposito, Giovanni ^a   Serra, Pierandrea ^a   Migheli, Rossana ^a   De Natale, Guglielmo ^a   Desole, Maria S ^a   Miele, Maddalena ^a   Miele, Egidio ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Ascorbic acid; Dopamine metabolism; Glutamate; Morphine; Naloxone; Striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; ASCORBIC ACID; GLUTAMIC ACID; HOMOVANILLIC ACID; MORPHINE; NALOXONE; OPIATE RECEPTOR; URIC ACID; XANTHINE;

AEROBIC METABOLISM; AMINO ACID ANALYSIS; ANIMAL EXPERIMENT; ARTICLE; DIALYSATE; DOPAMINE METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; ULTRAVIOLET RADIATION;

3,4-DIHYDROXYPHENYLACETIC ACID; ANALGESICS, OPIOID; ANIMALS; ASCORBIC ACID; CORPUS STRIATUM; DOPAMINE; GLUTAMIC ACID; HOMOVANILLIC ACID; HYDROXYINDOLEACETIC ACID; LOCOMOTION; MALE; MICRODIALYSIS; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; URIC ACID;

EID: 0032557867     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00371-0     Document Type: Article

References (39)

1. Aghajanian G.K., Kogan J.H., Moghaddam B. Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study. Brain Res. 636:1994;126-130.
2. Ahtee L., Attila L.M.J. Cerebral monoamine neurotransmission in opiod withdrawal and dependence. Med. Biol. 65:1987;113-119.
3. Ahtee L., Attila L.M.J., Carlson K.R., Haikala H. Changes in brain monoamine metabolism during withdrawal from chronic oral self-administration of morphine and in response to a morphine challenge in the withdrawal state. J. Pharmacol. Exp. Ther. 249:1989;303-310.
4. Akaoka H., Aston-Jones G. Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input. J. Neurosci. 11:1991;3830-3939.
5. Attila L.M.J., Ahtee L. Retardation of cerebral dopamine turnover after morphine withdrawal and its enhanced acceleration by acute morphine administration in rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 327:1984;201-207.
6. Becker B.B. Towards the physiological function of uric acid. Free Rad. Biol. Med. 14:1993;615-631.
7. Chesselet M.F., Chéramy A., Reisine T.D., Glowinsly J. Morphine and δ-opiate agonists locally stimulate in vivo dopamine in rat caudate nucleus. Nature. 291:1981;320-322.
8. C.C. Chiueh, Auto-oxidation of dopamine and formation of free radicals in vivo, in: A. Louilot, A.T. Durkin, U. Spampinato, M. Cador (Eds.), Monitoring Molecules in Neuroscience, Universities of Bordeaux, 1994, pp. 127-128.
9. De Angeli L. Ascorbic acid and a typical antipsychotic drugs: modulation of aminopeptine-induced behavior in mice. Brain Res. 670:1995;303-307.
10. Desole M.S., Miele M., Enrico P., Fresu L., Esposito G., De Natale G., Miele E. The effects of cortical ablation on D-amphetamine-induced changes in striatal dopamine turnover and ascorbic acid catabolism in the rat. Neurosci. Lett. 139:1992;29-33.
11. Desole M.S., Esposito G., Fresu L., Migheli R., Enrico P., Mura M.A., De Natale G., Miele E., Miele M. Effects of morphine treatment and withdrawal on striatal and limbic monoaminergic activity and ascorbic acid oxidation in the rat. Brain Res. 723:1996;154-161.
12. Di Chiara G., Imperato A. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244:1988;1067-1080.
13. Dourmap N., Michael-Titus A., Costentin J. Differential effect of intrastriatal kainic acid on the modulation of dopamine release by μ- and δ-opioid peptides: a microdialysis study. J. Neurochem. 58:1992;709-713.
14. Dourmap N., Clero E., Costentin J. Involvement of cholinergic neurons in the release of dopamine elicited by stimulation of μ-opioid receptors in striatum. Brain Res. 746:1997;295-300.
15. Enrico P., Esposito G., Mura M.A., Fresu L., De Natale G., Miele E., Desole M.S., Miele M. Effect of morphine on striatal dopamine metabolism and ascorbic acid and uric acid release in freely moving rats. Brain Res. 745:1997;173-182.
16. P. Enrico, G. Esposito, M.A. Mura, R. Migheli, P.A. Serra, M.S. Desole, E. Miele, G. De Natale, M. Miele, Effects of allopurinol on striatal dopamine, ascorbate and uric acid during an acute morphine challenge: ex vivo and in vivo studies, Pharmacol. Res., 1997, 577-585.
17. Gunne L.H., Jonsson J., Fuxe K. Morphine intoxication on brain catecholamines neurones. J. Eur. Pharmacol. 5:1969;338-342.
18. Gysling K., Wang R.Y. Morphine-induced activation of A10 dopamine neurons in the rat. Brain Res. 277:1983;119-127.
19. Honkanen A., Piepponen T.P., Ahtee L. Morphine-stimulated metabolism of striatal and limbic dopamine is dissimilarly sensitized in rats upon withdrawal from chronic morphine treatment. Neurosci. Lett. 180:1994;119-122.
20. Huang N.K., Tseng C.J., Womg C.S., Tung C.S. Effects of acute and chronic morphine on DOPAC and glutamate at subcortical DA terminals in awake rats. Pharmacol. Biochem. Behav. 56:1997;363-371.
21. Iwatsubo K., Clouet D. Effect of porphine and haloperidol on electrical activity of rat nigrostriatal neurons. J. Pharmacol. Exp. Ther. 202:1977;429-436.
22. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurones. J. Neurosci. 12:1992;483-488.
23. Johnston P.A., Chahl L.A. Chronic treatment with ascorbic acid inhibits the morphine withdrawal response in guinea-pigs. Neurosci. Lett. 135:1992;23-37.
24. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
25. Khanna N.C., Sharma S.K. Megadoses of vitamin C prevent the development of tolerance and physical dependence on morphine in mice. Life Sci. 33:1983;401-404.
26. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:1992;177-184.
27. Libby A.F., Stone L. The hypoascorbemia-kwashiorkor approach to drug addiction therapy: a pilot study. J. Orthomol. Psychiatry. 6:1977;300-308.
28. Marek P., Ben-Eliyahu S., Gold M., Liebeskind J.C. Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res. 547:1991;77-81.
29. Miele M., Boutelle M.G., Fillenz M. The physiologically-induced release of ascorbate in rat brain is dependent on impulse traffic, calcium influx and glutamate uptake. Neuroscience. 62:1994;87-91.
30. Miele M., Enrico P., Esposito G., Fresu L., Migheli R., De Natale G., Desole M.S. Cortical ablation and drug-induced changes in striatal ascorbic acid oxidation and behavior in the rat. Pharmacol. Biochem. Behav. 50:1995;1-7.
31. Morton D.B., Griffiths P.H.M. Guidelines on the recognition of pain, distress and discomfort in experimental animals and a hypothesis for assessment. Vet. Records. 116:1985;431-436.
32. R.D. O'Neill, The measurement of brain ascorbate in vivo and its link with excitatory amino acid neurotransmission, in: A. Boulton, G. Baker, R.N. Adams (Eds.), Neuromethods, Vol. 27: Voltammetric Methods in Brain Systems, Humana Press, 1995, pp. 221-268.
33. G. Paxinos, C. Watson, Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego, 1986.
34. Rebec G.V., Pierce C.P. A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Prog. Neurobiol. 43:1994;537-565.
35. Tao R., Auerbach S.B. Increased extracellular serotonin in rat brain after systemic or intraraphe administration of morphine. J. Neurochem. 63:1994;517-524.
36. Tanganelli S., Antonelli T., Morari M., Bianchi C., Beani L. Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs. Neurosci. Lett. 122:1991;270-272.
37. Trujillo K.A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 251:1991;85-87.
38. Yonehara N., Clouet D.H. Effects of delta and mu opiopeptides on the turnover and release of dopamine in rat striatum. J. Pharmacol. Exp. Ther. 231:1984;38-42.
39. Zhang T., Feng Y., Rockhold R.W., Ho I.K. Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat. Life Sci. 55:1994;25-31.